期刊文献+

法国与加拿大药品监管机构设置与启示 被引量:4

France and Canada Drug Regulatory Agencies and Implication
下载PDF
导出
摘要 药品监管机构是实施市场监管的主体,其设置模式与监管组织体系直接影响着政府监管的效率和药品市场的发展活力。本文以法国与加拿大的药品监管机构为研究对象,通过查阅两国药品监管官方网站和相关文献,对药品监管局的责任主体、组织机构和监管人员等方面进行了归纳总结,并与我国药监机构设置与职能进行了深入的比较,为我国药品监管体系的建设与发展提供了意见与建议。 Drug regulatory agency is the main body of implementing market regulation, the setting pattern and organizational system directly affects the efficiency of government regulation and the development of the pharmaceutical market's vitality. In this article France and Canada drug regulatory agencies were selected the research object. By searching their drug regulatory official websites and related literatures, we summarized the main responsibility of the drug administration, organization and supervisor and compared with drug regulatory institution setting and function of our country. The comments and suggestions were put forward for the construction and development of China's drug regulatory system
出处 《中国药物警戒》 2013年第9期536-539,542,共5页 Chinese Journal of Pharmacovigilance
关键词 法国 加拿大 药品监管机构 启示 France Canada regulatory agency implication
  • 相关文献

参考文献8

  • 1陈祥君,叶露.法国药品管理体制及其对中国的借鉴[J].中国卫生资源,2010,13(3):148-150. 被引量:9
  • 2Ansis Helmanis, Reglink, Alexander Gaffney. France: New Agencyto Soon Replace AFSSAPS, [EB/OL]. (2012-05-0) [2013-07-07].http://wwwj-aps.org/focus-online/news/news-article-view/arti-cle/1403/france-new-agency-to~soon-replace-afssaps.aspx.
  • 3ANSM.L'ANSM, agence d' . valuation, d'expertise et de decision[EB/OL].(2012-06-19)[2013-07-07]Jittp://ansm.sante.fr/L-ANSM2/Une-agence-d-expeitise/L-ANSM-agence^d-evaluation-d-ejqjeitise-et-de-decision/(offset)/0.
  • 4ANSM.Grganisation[EB/OL].(2013-07-15)[2013-07-07].http://ansm.sante.fr/L-ANSM2/Organisation/L - organisation-inteme/(offsetyO.
  • 5刘宝.加拿大药品管理系统介绍[J].中国药房,2009,20(1):15-18. 被引量:3
  • 6Health Canada. Regulating Pharmaceutical Drugs-Health CanadatEB/OL].(201X-ll-22)[2013-07-07].http://www.oag-bvg.gc.ca/intemet/english/parl_oag_20111 l_04_e_35936.html.
  • 7Health Canada. Therapeutic Products Directorate[EB/OL] .(2011-08-15)[2013-07-07]Jhittp://wwwJic-sc.gc.ca/ahc-asc/branch-dirgen/hpfb-dgpsa/tpd-dpt/index-eng.php.
  • 8Health Canada. Marketed Health Products Directorate [EB/OL].(2012-07-31)[2013-07-07] .http://www.hc-sc.gc.ca/ahc-asc/branch-dirgen/hpfb-dgpsa/mhpd-dpsc/index-eng.php.

二级参考文献20

  • 1Marchildon GP. Health Systems in Tnansition : Canada [ M ] . Toronto: University of Toronto Press, 2006: 1--17.
  • 2United Nations Development Programme. Human Development Report 2007/2008[ R] . New York: United Nations Development Programme, 2007: 229--234.
  • 3World Health Organization. World Health Statistics 2008[Z] . Geneva: World Health Organization, 2008: 35-- 103.
  • 4World Health Organization. World Health Report 2000 [R] . Health Systems: lmporving Performance. Geneva : World Health Organization, 2000:152.
  • 5Canadian Institute for Health Information. Drug Expenditure in Canada : 1985 to 2007[Z] .Ottawa: Canadian Institute for Health Information, 2008: 3-- 36.
  • 6Patented Medicine Prices Review Board. Annual Report 2007[R] . Ottawa: Patented Medicine Prices Review Board, 2008: 2-- 62.
  • 7Organization for Economic Co- operation and Development. OECD Health Data 2006[Z] .Paris. Organi- zation for Economic Cooperation and Development and IRDES, 2006.
  • 8Health Canada. Branches and Agencies [ EB/OL ] . http: //www. he- so.go.ca/ ahc- asc/ branch-dirgen/index - eng. php.2008 - 11 - 01.
  • 9Canadian Agency for Drugs and Technologies in Health. CDR Overview [EB/OL] . http..// cadth.ca/index.php/en/edr/cdr - overview.2008 - 11 01.
  • 10Canadian Agency for Drugs and Technologies in Health. Common Drug Review Process[EB/ OL] . http:// cadth, ca/media/edr/process/cdrflowchart april _e. pdf.2008- 11 - 01.

共引文献10

同被引文献18

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部